Sample Size Determination for Individual Bioequivalence Inference
Statistical criterion for evaluation of individual bioequivalence (IBE) between generic and innovative products often involves a function of the second moments of normal distributions. Under replicated crossover designs, the aggregate criterion for IBE proposed by the guidance of the U.S. Food and D...
Main Authors: | Chiang, Chieh, Hsiao, Chin-Fu, Liu, Jen-Pei |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195669/ |
Similar Items
-
Determination of Actarit from Human Plasma for Bioequivalence Studies
by: Loya, P., et al.
Published: (2010) -
Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation
by: Koenig, Franz, et al.
Published: (2015) -
Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
by: Zhao, Xiao-Ying, et al.
Published: (2013) -
Bioequivalence: tried and tested
by: Schall, Robert, et al.
Published: (2010) -
Bioequivalence assessment of two formulations of ibuprofen
by: Al-Talla, Zeyad A, et al.
Published: (2011)